Literature DB >> 42483

Beta-adrenoceptor-blocking agents: pharmacokinetic differences and their clinical implications illustrated on pindolol.

J Meier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 42483

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


× No keyword cloud information.
  7 in total

1.  Atenolol overdosage in a patient with progressive renal failure.

Authors:  D W Giang; D M Isaeff
Journal:  West J Med       Date:  1986-07

2.  Unsuitability of urethane anesthetized rats for testing potential beta-adrenoreceptor blockers.

Authors:  C A Maggi; A Meli
Journal:  Experientia       Date:  1982-04-15

3.  Pharmacokinetics of pindolol in Kenyan Africans.

Authors:  F D Juma
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Metabolism of pindolol in patients with renal failure.

Authors:  E E Ohnhaus; H Heidemann; J Meier; G Maurer
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Pharmacokinetics of bisoprolol during repeated oral administration to healthy volunteers and patients with kidney or liver disease.

Authors:  W Kirch; I Rose; H G Demers; G Leopold; J Pabst; E E Ohnhaus
Journal:  Clin Pharmacokinet       Date:  1987-08       Impact factor: 6.447

6.  A pharmacodynamic and pharmacokinetic comparison of pindolol 20 mg retard and a conventional tablet.

Authors:  W H Aellig; H H Narjes; E Nüesch; R J Oertle; J E Devos; W Pacha
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

7.  Elimination of pindolol in liver disease.

Authors:  E E Ohnhaus; U Münch; J Meier
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.